Clinical trial

Spironolactone in Diabetic Nephropathy

NCT00317954

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-09-01

PhasePHASE4

Study timeline

Study start (unknown)2003-09-01Date precision: month

Registry last updated2006-04-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Nephropathyverified · MONDO: diabetic kidney disease

Interventions

SpironolactoneDRUG · verified · RxNorm: spironolactone

Sponsors & collaborators

Steno Diabetes Center Copenhagenlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00317954 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.